Healthcare
Live Price
Offline$4.85
+0.00% today
1Y Change
-41.28%
Window
Jun 25, 2025 → Jun 23, 2026
Coverage: 249 bars · Jun 25, 2025 → Jun 23, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Cybin Inc. (CYBN) is a Healthcare stock with a market cap of $130.00M and listed on NYSE. The stock last traded around $4.85 and down 41.3% across the available one-year price window (Jun 25, 2025 → Jun 23, 2026). Baseline metrics include revenue growth of 0.0%, EPS growth of +93.6%, a dividend yield of 0.0%. What stands out right now is revenue 0.0%, EPS +93.6%, free cash flow -48.3% with operating margin 0.0% and ROIC -50.7%. Stock Foundry combines CYBN price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
CYBN
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
CYBN Max Drawdown
-57.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CYBN and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$864.0K
FY Net Income
-$32.2M
+54.9% YoY
Free Cash Flow
-$19.3M
+0.0% YoY
Revenue Growth
+0.0%
EPS Growth
+93.6%
Gross Margin
0.0%
Net Margin
0.0%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 864K |
| Gross Profit | 0 | -424K | -251K | -168K | 200K |
| Operating Income | -143M | -79M | -52M | -64M | -31M |
| EBITDA | -143M | -79M | -51M | -64M | -32M |
| Net Income | -113M | -78M | -40M | -71M | -32M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 135M | 209M | 54M | 64M | 2M |
| Total Assets | 259M | 302M | 84M | 92M | 2M |
| Total Liabilities | 21M | 10M | 8M | 6M | 263K |
| Shareholder Equity | 237M | 292M | 76M | 86M | 1M |
| Total Debt | 0 | 291K | 0 | 0 | 0 |
| Net Debt | -135M | -209M | -54M | -64M | -2M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
19M
+0.0% YoY
Capital Expenditures
231K
+0.0% YoY
Free Cash Flow
19M
+0.0% YoY
Key ratios
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-61.5%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.